[Form 4] TAO Synergies Inc. Insider Trading Activity

Rhea-AI Filing Summary

TAO Synergies (TAOX) insider filed a Form 4 reporting equity awards and related share movements. On 10/17/2025, the Executive Chairman/Director received 100,000 restricted stock units under the 2020 Equity Incentive Plan, which vested immediately. To cover taxes upon vesting, 40,000 shares were withheld by the company at a price of $7.23, a non‑open‑market transaction.

Following these transactions, the insider beneficially owns 86,681 shares. Separately, an employee stock option for 36,000 shares with an exercise price of $10.38 was reported, exercisable 07/14/2026 and expiring 07/14/2035. The option grant was approved on 07/14/2025, subject to shareholder approval of a plan amendment, which the company received on 08/06/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Silverman Joshua

(Last) (First) (Middle)

C/O TAO SYNERGIES INC.

1185 AVENUE OF THE AMERICAS, 3RD FLOOR

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TAO Synergies Inc. [ TAOX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	10/17/2025		A		100,000	A	$0.00	126,681(1)	D
Common Stock, par value $0.0001 per share	10/17/2025		F		40,000(2)	D	$7.23	86,681	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$10.38	08/06/2025(3)		A		36,000		07/14/2026	07/14/2035	Common Stock	36,000	$0	36,000	D

Explanation of Responses:

1. Includes (i) 100,000 restricted stock units granted on October 17, 2025, under TAO Synergies Inc.'s (the "Issuer") 2020 Equity Incentive Plan which vested immediately and (ii) 26,681 shares of common stock.

2. Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.

3. The option grant was approved by a committee of the Issuer's board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025.

	/s/ Robert Weinstein, Attorney-in-fact	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did TAOX’s insider report on Form 4?

An award of 100,000 RSUs that vested on 10/17/2025, tax withholding of 40,000 shares at $7.23, and an option for 36,000 shares at $10.38.

How many TAOX shares does the insider own after the transactions?

The filing reports 86,681 shares beneficially owned following the reported transactions.

Were any TAOX shares sold on the open market?

No. The 40,000 shares were withheld by the issuer to satisfy taxes upon RSU vesting, not sold in the open market.

What are the terms of the newly reported stock options for TAOX?

The insider holds 36,000 options at an exercise price of $10.38, exercisable 07/14/2026 and expiring 07/14/2035.

What approvals were required for the TAOX option grant?

The option grant was approved on 07/14/2025, subject to shareholder approval of a plan amendment, which was received on 08/06/2025.

Which plan governed the RSU grant reported by TAOX?

The 2020 Equity Incentive Plan of TAO Synergies Inc. governed the 100,000 RSU grant.